C-19 (University of Pittsburgh)

N/A

Report date: 2025/03/14 16:27:52
NME

Base Information

Drug NameC-19 (University of Pittsburgh)
Drug Alias NameHippo/Wnt/TGF-beta pathways inhibitor (University of Pittsburgh)C-19
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta inhibitorsWingless type MMTV integration site family protein inhibitors
TargetsTransforming growth factor betaWingless type MMTV integration site family protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pittsburgh
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Pittsburgh
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A